Detalhe da pesquisa
1.
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer.
N Engl J Med
; 385(25): 2336-2347, 2021 12 16.
Artigo
Inglês
| MEDLINE | ID: mdl-34914339
2.
Clinical and Sociodemographic Determinants of Adherence to World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Recommendations in Breast Cancer Survivors-Health-EpiGEICAM Study.
Cancers (Basel)
; 14(19)2022 Sep 27.
Artigo
Inglês
| MEDLINE | ID: mdl-36230628
3.
Molecular basis of hypertension side effects induced by sunitinib.
Anticancer Drugs
; 22(1): 1-8, 2011 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-20938340
4.
Maintenance treatment with pegylated liposomal doxorubicin versus observation following induction chemotherapy for metastatic breast cancer: GEICAM 2001-01 study.
Breast Cancer Res Treat
; 122(1): 169-76, 2010 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-20361253
5.
Serum Phospholipids Fatty Acids and Breast Cancer Risk by Pathological Subtype.
Nutrients
; 12(10)2020 Oct 14.
Artigo
Inglês
| MEDLINE | ID: mdl-33066483
6.
First-line panitumumab plus capecitabine for the treatment of older patients with wild-type RAS metastatic colorectal cancer. The phase II, PANEL study.
J Geriatr Oncol
; 11(8): 1263-1267, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32580916
7.
Primary breast cancer and health related quality of life in Spanish women: The EpiGEICAM case-control study.
Sci Rep
; 10(1): 7741, 2020 05 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32385335
8.
Overeating, caloric restriction and breast cancer risk by pathologic subtype: the EPIGEICAM study.
Sci Rep
; 9(1): 3904, 2019 03 07.
Artigo
Inglês
| MEDLINE | ID: mdl-30846706
9.
A phase II study of weekly vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer.
Clin Breast Cancer
; 8(3): 264-8, 2008 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-18650157
10.
Long-term response to first-line bevacizumab-based therapy in patients with metastatic breast cancer: results of the observational "LORENA" study.
Onco Targets Ther
; 11: 5845-5852, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30271167
11.
Primary results of ROSE/TRIO-12, a randomized placebo-controlled phase III trial evaluating the addition of ramucirumab to first-line docetaxel chemotherapy in metastatic breast cancer.
J Clin Oncol
; 33(2): 141-8, 2015 Jan 10.
Artigo
Inglês
| MEDLINE | ID: mdl-25185099
12.
MicroRNA expression profiling of peripheral blood samples predicts resistance to first-line sunitinib in advanced renal cell carcinoma patients.
Neoplasia
; 14(12): 1144-52, 2012 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-23308047